Mannatech, Incorporated (NASDAQ:MTEX) Short Interest Up 112.2% in December

Mannatech, Incorporated (NASDAQ:MTEX) was the target of a large increase in short interest during the month of December. As of December 31st, there was short interest totaling 24,659 shares, an increase of 112.2% from the December 15th total of 11,621 shares. Based on an average daily trading volume, of 31,236 shares, the short-interest ratio is presently 0.8 days. Approximately 2.2% of the shares of the company are short sold. Approximately 2.2% of the shares of the company are short sold. Based on an average daily trading volume, of 31,236 shares, the short-interest ratio is presently 0.8 days.

Mannatech Stock Performance

Shares of Mannatech stock traded up $1.53 during trading on Thursday, hitting $9.13. 407,801 shares of the stock were exchanged, compared to its average volume of 34,227. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.56 and a current ratio of 1.13. Mannatech has a 12 month low of $6.90 and a 12 month high of $16.49. The stock’s fifty day moving average is $8.81 and its 200 day moving average is $8.80. The stock has a market cap of $17.36 million, a PE ratio of -10.62 and a beta of 0.79.

Mannatech (NASDAQ:MTEX) last issued its quarterly earnings data on Wednesday, November 12th. The company reported $1.01 earnings per share for the quarter. Mannatech had a negative net margin of 1.50% and a negative return on equity of 22.75%. The firm had revenue of $29.16 million for the quarter.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Mannatech in a research note on Monday, December 22nd. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Mannatech presently has a consensus rating of “Sell”.

Mannatech Company Profile

Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.

The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.